Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Tate & Lyle Solutions Usa LLC is managing 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 4 distinct art units and 4 distinct examiners. LANKFORD JR, LEON B is the busiest examiner for the company, currently handling 1 pending action. The use of 4 distinct examiners for 4 actions means that no single examiner has a dominant role in the company's current pending portfolio.
This one-to-one ratio between the 4 pending office actions and the 4 distinct examiners requires a versatile prosecution strategy. Each examiner may have a different approach to the Biotechnology & Pharmaceuticals field, and the 4 distinct art units involved suggest a variety of technical sub-specialties. LANKFORD JR, LEON B, while listed as the busiest, is only responsible for one-fourth of the pending actions. Practitioners must be prepared to navigate four different sets of procedural requirements and examiner preferences. This distribution across 4 distinct art units ensures that the company's pharmaceutical innovations are being reviewed by a diverse group of experts, spreading the prosecution risk evenly across the 4 pending office actions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LANKFORD JR, LEON B | 1 | 70.0% | +31.5% |
| MCNEIL, JENNIFER C | 1 | 23.7% | +20.0% |
| LIU, DEBORAH YANG-HAO | 1 | 8.9% | +12.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17780737 | High-Fiber, Low-Sugar Soluble Dietary Fibers, Products Including Them and Methods for Making and Using Them | LIU, DEBORAH YANG-HAO | 73d overdue |
| 18852045 | METHOD FOR ARABINOXYLAN OLIGOSACCARIDE EXTRACTION FROM CORN MATERIAL | LANKFORD JR, LEON B | — |
| 18241557 | GLYCOSYLATED STEVIOL GLYCOSIDE COMPOSITIONS AND METHODS OF PREPARING GLYCOSYLATED STEVIOL GLYCOSIDE COMPOSITIONS | MCNEIL, JENNIFER C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17780737 | High-Fiber, Low-Sugar Soluble Dietary Fibers, Products Including Them and Methods for Making and Using Them | LIU, DEBORAH YANG-HAO | 73d overdue |
| 18852045 | METHOD FOR ARABINOXYLAN OLIGOSACCARIDE EXTRACTION FROM CORN MATERIAL | LANKFORD JR, LEON B | — |
| 18241557 | GLYCOSYLATED STEVIOL GLYCOSIDE COMPOSITIONS AND METHODS OF PREPARING GLYCOSYLATED STEVIOL GLYCOSIDE COMPOSITIONS | MCNEIL, JENNIFER C | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| 1793 | 1 |
| 1791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18852045 | METHOD FOR ARABINOXYLAN OLIGOSACCARIDE EXTRACTION FROM CORN MATERIAL | LANKFORD JR, LEON B | 1657 | §102§103 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18241557 | GLYCOSYLATED STEVIOL GLYCOSIDE COMPOSITIONS AND METHODS OF PREPARING GLYCOSYLATED STEVIOL GLYCOSIDE COMPOSITIONS | MCNEIL, JENNIFER C | 1793 | §103§112 | Final Rejection | — | Pending | Sep 01, 2023 |
| 17780737 | High-Fiber, Low-Sugar Soluble Dietary Fibers, Products Including Them and Methods for Making and Using Them | LIU, DEBORAH YANG-HAO | 1791 | §103 | Non-Final OA | 73d overdue | Pending | May 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTate & Lyle Solutions Usa LLC has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Leon B Lankford Jr. has the most, with 1 of Tate & Lyle Solutions Usa LLC's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
